Glial Fibrillary Acidic Protein (GFAP) Autoimmunity in the Setting of Seropositive Rheumatoid Arthritis Treated With Etanercept
- 1 September 2019
- journal article
- research article
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 24 (5) , 152-154
Abstract
Introduction: Glial fibrillary acidic protein (GFAP) immunoglobulin G is a recently discovered biomarker of an autoimmune central nervous system disorder characterized by a steroid-responsive meningoencephalomyelitis. Case Report: A 63-year-old man with rheumatoid arthritis on etanercept presented with steroid-responsive subacute encephalopathy and foot drop. Brain and sural nerve biopsies demonstrated a T-cell perivascular infiltrate. Cerebrospinal fluid studies 18 months into the course of the illness demonstrated a GFAP antibody on mouse tissue immunofluorescence confirmed by cell-based assay. The patient was treated with steroids and cyclophosphamide leading to resolution of his symptoms. Conclusion: This case expands on the previously reported cases of GFAP immunoglobulin G autoimmunity by describing an associated inflammatory large fiber peripheral neuropathy.Keywords
This publication has 7 references indexed in Scilit:
- Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective studyEuropean Journal of Neurology, 2017
- Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2017
- CNS Demyelination with TNF-α BlockersCurrent Neurology and Neuroscience Reports, 2017
- Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patientsAnnals of Neurology, 2017
- Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyJAMA Neurology, 2016
- Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarkerTrends in Neurosciences, 2015
- Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics ApproachPLOS ONE, 2013